Skip to main content

Utpal Koppikar

Equibles does not estimate personal net worth.

Get an email with a short summary when C4 Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get CCCC alerts

About Utpal Koppikar

Utpal Koppikar is recorded as Board Member at C4 Therapeutics, Inc. (CCCC) since March 16, 2022. C4 Therapeutics, Inc. reported in an 8-K filed March 16, 2022 that Utpal Koppikar was appointed director, effective March 16, 2022. C4 Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at C4 Therapeutics, Inc. includes Andrew J. Hirsch (CEO), Andrew Phillips (CEO), Ron Cooper (Chairman and Board Member) and 7 others.

“On March 16, 2022, the Board of Directors (the “Board”) of C4 Therapeutics, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Utpal Koppikar as a director effective immediately and as chair of the Audit Committee of the Board effective March 17, 2022.”
C4 Therapeutics, Inc. Form 8-K, filed March 16, 2022 · Read the filing

Affiliation history

Company network

Leadership on record at C4 Therapeutics, Inc.

Recent activity